Australian medical technology company, Global Kinetics Corporation, is proud to be working with neurologist and Parkinson’s UK-funded researcher, Dr Alastair Noyce from the Institute of Neurology, University College London, to help spot early warning signs of Parkinson’s.
30 January, 2017
The topic of this month’s newsletter from Drug Discovery Today is “The Best of 2016”.
27 January, 2017
NiCoLA-B, the world’s most advanced drug discovery robot, is teaming up with scientists from Cancer Research UK (CRUK) and the Medical Research Council (MRC), through AstraZeneca’s Open Innovation research collaboration programme. The new robot, which can test up to 300,000 compounds a day, is designed to make drug discovery smarter, faster and cheaper. It can work three times more quickly than previous drug discovery robots and can sense and adapt to the presence of its human workmates. This means it can share their workspace without protective guarding.
23 January, 2017
A team of scientists led by prof. Adrian Liston (VIB–KU Leuven) and prof. Isabelle Meyts (UZ Leuven – KU Leuven) were able to characterize a new genetic immunodeficiency resulting from a mutation in a gene named STAT2. This mutation causes patients to be extremely vulnerable to normally mild childhood illnesses such as rotavirus and enterovirus. Prof. Liston’s comprehensive analysis of the genetic defect allows clinicians to provide children with the proper therapies before illnesses prove fatal. The findings of the research have been published in the Journal of Allergy and Clinical Immunology.
20 January, 2017
Cancer Research UK, Cancer Research Technology and MRC Technology are joining forces to identify and validate novel drug discovery targets that could lead to new immunotherapy treatments.
19 January, 2017
Move to Nine, Edinburgh BioQuarter offers increase in laboratory and office space
18 January, 2017
The use of benzodiazepines and benzodiazepine-like drugs was associated with a 20 per cent increased risk of stroke among persons with Alzheimer’s disease, shows a recent study from the University of Eastern Finland. Benzodiazepines were associated with a similar risk of stroke as benzodiazepine-like drugs.
17 January, 2017